This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

George C. Brdlik
Food and Drug Administration Bureau of Medical Devices Silver Spring, Md

JAMA. 1981;245(8):822.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

I would like to add to the discussion between Graybeal and Schmidt (1980;244:332) on intravenous infusion filters. The important issue of the additional cost of routine filtration has been recently addressed by the National Coordinating Committee on Large Volume Parenterals (NCCLVP). In recommendations approved on Nov 30, 1979,¹ the NCCLVP has paid special attention to identifying the most appropriate clinical applications of filters, including the most suitable type of filter for a given situation. Rather than try to abstract these recommendations here, I urge clinicians involved in parenteral fluid therapy to refer to the original document for additional guidance.

Another problem not discussed by Graybeal and Schmidt is that of incompatibility of filters with many of the infusion pumps currently on the market. The pressure that some pumps can generate can damage some filters and integral filter administration sets, creating potentially unsafe conditions for the patient.² . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?